Joel M Reid, PhD

  • 7294 Citations
  • 44 Scopus h-Index
1976 …2019
If you made any changes in Pure, your changes will be visible here soon.

Research Output 1989 2019

  • 7294 Citations
  • 44 Scopus h-Index
  • 169 Article
  • 1 Comment/debate
2019

Anastrozole Aromatase Inhibitor Plasma Drug Concentration Genome-Wide Association Study: Functional Epistatic Interaction Between SLC38A7 and ALPPL2

Dudenkov, T. M., Liu, D., Cairns, J., Devarajan, S., Zhuang, Y., Ingle, J. N., Buzdar, A. U., Robson, M. E., Kubo, M., Batzler, A., Barman, P., Jenkins, G. D., Carlson, E. E., Goetz, M. P., Northfelt, D. W., Moreno Aspitia, A., Desta, Z., Reid, J. M., Kalari, K. R., Wang, L. M. & 1 others, Weinshilboum, R. M., Jan 1 2019, In : Clinical pharmacology and therapeutics.

Research output: Contribution to journalArticle

Open Access
Aromatase Inhibitors
Genome-Wide Association Study
Single Nucleotide Polymorphism
Pharmaceutical Preparations
Breast Neoplasms
2 Citations (Scopus)

A phase II study of alisertib in children with recurrent/refractory solid tumors or leukemia: Children's Oncology Group Phase I and pilot Consortium (ADVL0921)

Mosse, Y. P., Fox, E., Teachey, D. T., Reid, J. M., Safgren, S. L., Carol, H., Lock, R. B., Houghton, P. J., Smith, M. A., Hall, D., Barkauskas, D. A., Krailo, M., Voss, S. D., Berg, S. L., Blaney, S. M. & Weigel, B. J., Jun 1 2019, In : Clinical Cancer Research. 25, 11, p. 3229-3238 10 p.

Research output: Contribution to journalArticle

Open Access
Leukemia
Aurora Kinase A
Neoplasms
Pharmacokinetics
Pharmacogenetics

Correction: Antibody-targeted chemotherapy for the treatment of melanoma (Cancer Research (2016) 76 (3954-3964) DOI: 10.1158/0008-5472.CAN-15-3131)

Nevala, W. K., Buhrow, S. A., Knauer, D. J., Reid, J. M., Atanasova, E. A. & Markovic, S. N., Sep 1 2019, In : Cancer Research. 79, 17, 1 p.

Research output: Contribution to journalComment/debate

Open Access
Melanoma
Emotions
Drug Therapy
Antibodies
Research
2 Citations (Scopus)

Pharmacogenomic next-generation DNA sequencing: Lessons from the identification and functional characterization of variants of unknown significance in CYP2C9 and CYP2C19

Devarajan, S., Moon, I., Ho, M. F., Larson, N., Neavin, D. R., Moyer, A., Black, J. L., Bielinski, S. J., Scherer, S. E., Wang, L. M., Weinshilboum, R. M. & Reid, J. M., Apr 1 2019, In : Drug Metabolism and Disposition. 47, 4, p. 425-435 11 p.

Research output: Contribution to journalArticle

Pharmacogenetics
DNA Sequence Analysis
Cytochrome P-450 Enzyme System
Oxidoreductases
Proteins

Pharmacogenomics of cytochrome p450 of nimodipine metabolism after aneurysmal subarachnoid hemorrhage

Peacock, S. H., James, C., Turnbull, M. T., Cowart, J. B., Reid, J. M. & Freeman, W. D., Oct 1 2019, In : Journal of Neuroscience Nursing. 51, 5, p. 238-242 5 p.

Research output: Contribution to journalArticle

Nimodipine
Pharmacogenetics
Subarachnoid Hemorrhage
Cytochrome P-450 Enzyme System
Brain Ischemia

Phase II trial of the glycoprotein non-metastatic B-targeted antibody–drug conjugate, glembatumumab vedotin (CDX-011), in recurrent osteosarcoma AOST1521: A report from the Children's Oncology Group

Kopp, L. M., Malempati, S., Krailo, M., Gao, Y., Buxton, A., Weigel, B. J., Hawthorne, T., Crowley, E., Moscow, J. A., Reid, J. M., Villalobos, V., Randall, R. L., Gorlick, R. & Janeway, K. A., Nov 2019, In : European Journal of Cancer. 121, p. 177-183 7 p.

Research output: Contribution to journalArticle

Osteosarcoma
Glycoproteins
glembatumumab vedotin
Exanthema
Microtubules
2 Citations (Scopus)

Prediction of the Renal Elimination of Drugs With Cystatin C vs Creatinine: A Systematic Review

Barreto, E. F., Rule, A. D., Murad, M. H., Kashani, K. B., Lieske, J. C., Erwin, P. J., Steckelberg, J. M., Gajic, O., Reid, J. M. & Kane-Gill, S. L., Jan 1 2019, (Accepted/In press) In : Mayo Clinic Proceedings.

Research output: Contribution to journalArticle

Cystatin C
Creatinine
Pharmaceutical Preparations
Kidney
Acute Kidney Injury

Vaginal Diazepam for Nonrelaxing Pelvic Floor Dysfunction: The Pharmacokinetic Profile

Larish, A. M., Dickson, R. R., Kudgus, R. A., McGovern, R. M., Reid, J. M., Hooten, W. M., Nicholson, W. T., Vaughan, L. E., Burnett, T. L., Laughlin-Tommaso, S. K., Faubion, S. S. & Green, I. C., Jan 1 2019, In : Journal of Sexual Medicine.

Research output: Contribution to journalArticle

Pelvic Floor
Diazepam
Pharmacokinetics
Suppositories
Half-Life
2018
3 Citations (Scopus)

A phase 1 study of cabozantinib in children and adolescents with recurrent or refractory solid tumors, including CNS tumors: Trial ADVL1211, a report from the Children's Oncology Group

Chuk, M. K., Widemann, B. C., Minard, C. G., Liu, X., Kim, A. R., Bernhardt, M. B., Kudgus, R. A., Reid, J. M., Voss, S. D., Blaney, S., Fox, E. & Weigel, B. J., Aug 1 2018, In : Pediatric Blood and Cancer. 65, 8, e27077.

Research output: Contribution to journalArticle

Neoplasms
Maximum Tolerated Dose
Pharmacokinetics
Proteinuria
Fatigue
4 Citations (Scopus)

A phase 1 study of eribulin mesylate (E7389), a novel microtubule-targeting chemotherapeutic agent, in children with refractory or recurrent solid tumors: A Children's Oncology Group Phase 1 Consortium study (ADVL1314)

Schafer, E. S., Rau, R. E., Berg, S., Liu, X., Minard, C. G., D'Adamo, D., Scott, R., Reyderman, L., Martinez, G., Devarajan, S., Reid, J. M., Fox, E., Weigel, B. J. & Blaney, S. M., Jan 1 2018, (Accepted/In press) In : Pediatric Blood and Cancer.

Research output: Contribution to journalArticle

eribulin
Microtubules
Pharmacokinetics
Neutropenia
Neoplasms
9 Citations (Scopus)

A phase i clinical trial of the Poly(ADP-ribose) polymerase inhibitor veliparib and weekly topotecan in patients with solid tumors

Wahner Hendrickson, A. E., Menefee, M. E., Hartmann, L. C., Long, H. J., Northfelt, D. W., Reid, J. M., Boakye-Agyeman, F., Kayode, O., Flatten, K. S., Harrell, M. I., Swisher, E. M., Poirer, G. G., Satele, D., Allred, J., Lensing, J. L., Chen, A., Ji, J., Zang, Y., Erlichman, C., Haluska, P. & 1 others, Kaufmann, S. H., Feb 15 2018, In : Clinical Cancer Research. 24, 4, p. 744-752 9 p.

Research output: Contribution to journalArticle

Topotecan
Clinical Trials
Neoplasms
Maximum Tolerated Dose
Mutation
tipifarnib
Farnesyltranstransferase
Epidermal Growth Factor
Protein-Tyrosine Kinases
Maximum Tolerated Dose

A study of axitinib, a VEGF receptor tyrosine kinase inhibitor, in children and adolescents with recurrent or refractory solid tumors: A Children’s Oncology Group Phase 1 and Pilot Consortium Trial (ADVL1315)

Geller, J. I., Fox, E., Turpin, B. K., Goldstein, S. L., Liu, X., Minard, C. G., Kudgus, R. A., Reid, J. M., Berg, S. L. & Weigel, B. J., Jan 1 2018, (Accepted/In press) In : Cancer.

Research output: Contribution to journalArticle

Vascular Endothelial Growth Factor Receptor
Protein-Tyrosine Kinases
Neoplasms
Pharmacokinetics
Hypertension

Corticosteroid and Cortisol Serum Levels Following Intra-articular Triamcinolone Acetonide Lumbar Facet Joint Injections

Dickson, R. R., Reid, J. M., Nicholson, W. T., Lamer, T. J. & Michael Hooten, W., Jan 1 2018, (Accepted/In press) In : Pain Practice.

Research output: Contribution to journalArticle

Zygapophyseal Joint
Triamcinolone Acetonide
Hydrocortisone
Adrenal Cortex Hormones
Joints
1 Citation (Scopus)

Pharmacokinetics of dacarbazine (DTIC) in pregnancy

Kantrowitz-Gordon, I., Hays, K., Kayode, O., Kumar, A. R., Kaplan, H. G., Reid, J. M., Safgren, S. L., Ames, M. M., Easterling, T. R. & Hebert, M. F., Jan 5 2018, (Accepted/In press) In : Cancer Chemotherapy and Pharmacology. p. 1-6 6 p.

Research output: Contribution to journalArticle

Dacarbazine
Pharmacokinetics
5-(3-methyl-1-triazeno)imidazole-4-carboxamide
Aminoimidazole Carboxamide
Pregnancy
4 Citations (Scopus)

Phase 1 trial of ontuxizumab (MORAb-004) in children with relapsed or refractory solid tumors: A report from the Children's Oncology Group Phase 1 Pilot Consortium (ADVL1213)

Norris, R. E., Fox, E., Reid, J. M., Ralya, A., Liu, X. W., Minard, C. & Weigel, B. J., Jan 1 2018, (Accepted/In press) In : Pediatric Blood and Cancer.

Research output: Contribution to journalArticle

Neoplasms
Maximum Tolerated Dose
Pharmacokinetics
Antibodies, Monoclonal, Humanized
Ewing's Sarcoma
6 Citations (Scopus)

Phase II trial of alisertib in combination with irinotecan and temozolomide for patients with relapsed or refractory neuroblastoma

DuBois, S. G., Mosse, Y. P., Fox, E., Kudgus, R. A., Reid, J. M., McGovern, R., Groshen, S., Bagatell, R., Maris, J. M., Twist, C. J., Goldsmith, K., Meaghan Granger, M., Weiss, B., Park, J. R., Macy, M. E., Cohn, S. L., Yanik, G., Wagner, L. M., Hawkins, R., Courtier, J. & 9 others, Lai, H., Goodarzian, F., Shimada, H., Boucher, N., Czarnecki, S., Luo, C., Tsao-Wei, D., Matthay, K. K. & Marachelian, A., Dec 15 2018, In : Clinical Cancer Research. 24, 24, p. 6142-6149 8 p.

Research output: Contribution to journalArticle

irinotecan
temozolomide
Neuroblastoma
Tablets
Disease-Free Survival
2 Citations (Scopus)

Phase I study of vorinostat in combination with isotretinoin in patients with refractory/recurrent neuroblastoma: A new approaches to Neuroblastoma Therapy (NANT) trial

Pinto, N., Dubois, S. G., Marachelian, A., Diede, S. J., Taraseviciute, A., Glade Bender, J. L., Tsao-Wei, D., Groshen, S. G., Reid, J. M., Haas-Kogan, D. A., Reynolds, C. P., Kang, M. H., Irwin, M. S., Macy, M. E., Villablanca, J. G., Matthay, K. K. & Park, J. R., Jan 1 2018, (Accepted/In press) In : Pediatric Blood and Cancer.

Research output: Contribution to journalArticle

Isotretinoin
Neuroblastoma
Acetylation
Histones
Therapeutics
3 Citations (Scopus)

Serum Triamcinolone Levels following Cervical Interlaminar Epidural Injection

Lamer, T. J., Dickson, R. R., Gazelka, H. M., Nicholson, W. T., Reid, J. M., Moeschler, S. M. & Hooten, W. M., Jan 1 2018, In : Pain research & management. 2018, 1 p.

Research output: Contribution to journalArticle

Epidural Injections
Triamcinolone
Steroids
Serum
Half-Life
2017
3 Citations (Scopus)

A phase 1 study of the c-Met inhibitor, tivantinib (ARQ197) in children with relapsed or refractory solid tumors: A Children's Oncology Group study phase 1 and pilot consortium trial (ADVL1111)

Geller, J. I., Perentesis, J. P., Liu, X., Minard, C. G., Kudgus, R. A., Reid, J. M., Fox, E., Blaney, S. M. & Weigel, B. J., Nov 1 2017, In : Pediatric Blood and Cancer. 64, 11, e26565.

Research output: Contribution to journalArticle

Pharmacokinetics
Neoplasms
Proto-Oncogene Proteins c-met
Food
Powders
5 Citations (Scopus)

Comparison of Bioavailability of Single-Dose Extended-Release Venlafaxine Capsules in Obese Patients Before and After Gastric Bypass Surgery

Krieger, C. A., Cunningham, J. L., Reid, J. M., Langman, L. J., Grothe, K., Clark, M. M. & Dierkhising, R. A., 2017, (Accepted/In press) In : Pharmacotherapy.

Research output: Contribution to journalArticle

Gastric Bypass
Biological Availability
Capsules
Pharmacokinetics
Serum
22 Citations (Scopus)

First-in-human phase I Study of the tamoxifen metabolite Z-endoxifen in women with endocrine-refractory metastatic breast cancer

Goetz, M. P., Suman, V. J., Reid, J. M., Northfelt, D. W., Mahr, M. A., Ralya, A. T., Kuffel, M., Visscher, S. A., Kipp, B. R., Liu, M. C., Hawse, J. R., Ames, M. M., Ingle Buhrow, J. N., Safgren, S. L., McGovern, R. M., Black, J., Dockter, T., Haddad, T. C., Erlichman, C., Adjei, A. & 7 others, Collins, D., Streicher, H., Chalmers, Z. R., Frampton, G., Hawse, J. R., Doroshow, J. H. & Collins, J. M., Oct 20 2017, In : Journal of Clinical Oncology. 35, 30, p. 3391-3400 10 p.

Research output: Contribution to journalArticle

Tamoxifen
Breast Neoplasms
Maximum Tolerated Dose
Mutation
Cytochrome P-450 CYP2D6
1 Citation (Scopus)

Pediatric phase I trial and pharmacokinetic study of trebananib in relapsed solid tumors, including primary tumors of the central nervous system ADVL1115: A children's oncology group phase I consortium report

Leary, S. E. S., Park, J. R., Reid, J. M., Ralya, A. T., Baruchel, S., Wu, B., Roberts, T. P. L., Liu, X., Minard, C. G., Fox, E., Weigel, B. & Blaney, S., Oct 15 2017, In : Clinical Cancer Research. 23, 20, p. 6062-6070 9 p.

Research output: Contribution to journalArticle

Central Nervous System Neoplasms
Pharmacokinetics
Pediatrics
Neoplasms
Angiogenic Proteins
1 Citation (Scopus)

Skeletal and uterotrophic effects of endoxifen in female rats

Gingery, A., Iwaniec, U. T., Subramaniam, M., Turner, R. T., Pitel, K. S., McGovern, R. M., Reid, J. M., Marler, R. J., Ingle, J. N., Goetz, M. P. & Hawse, J. R., Oct 1 2017, In : Endocrinology. 158, 10, p. 3354-3368 15 p.

Research output: Contribution to journalArticle

Tamoxifen
Uterus
Bone and Bones
Epithelial Cells
Breast Neoplasms
2016
8 Citations (Scopus)

Antibody-targeted chemotherapy for the treatment of melanoma

Nevala, W. K., Buhrow, S. A., Knauer, D. J., Reid, J. M., Atanasova, E. A. & Markovic, S. N., Jul 1 2016, In : Cancer Research. 76, 13, p. 3954-3964 11 p.

Research output: Contribution to journalArticle

Melanoma
Drug Therapy
Nanoparticles
Antibodies
Paclitaxel
119 Citations (Scopus)

CD38 Dictates Age-Related NAD Decline and Mitochondrial Dysfunction through an SIRT3-Dependent Mechanism

Camacho-Pereira, J., Tarragó, M. G., Chini, C. C. S., Nin, V., Escande, C., Warner, G. M., Puranik, A. S., Schoon, R. A., Reid, J. M., Galina, A. & Chini, E. N., Jun 14 2016, In : Cell Metabolism. 23, 6, p. 1127-1139 13 p.

Research output: Contribution to journalArticle

NAD
Nicotinamide Mononucleotide
NAD+ Nucleosidase
Metabolic Diseases
Enzymes
14 Citations (Scopus)

Controlled delivery of vancomycin via charged hydrogels

Gustafson, C. T., Boakye-Agyeman, F., Brinkman, C. L., Reid, J. M., Patel, R., Bajzer, Z., Dadsetan, M. & Yaszemski, M. J., Jan 1 2016, In : PLoS One. 11, 1, e0146401.

Research output: Contribution to journalArticle

Hydrogels
vancomycin
hydrocolloids
Vancomycin
Surgical Wound Infection
30 Citations (Scopus)

Delineation of MGMT Hypermethylation as a Biomarker for Veliparib-Mediated Temozolomide-Sensitizing Therapy of Glioblastoma

Gupta, S. K., Kizilbash, S., Carlson, B. L., Mladek, A. C., Boakye-Agyeman, F., Bakken, K. K., Pokorny, J. L., Schroeder, M. A., Decker, P. A., Cen, L., Eckel-Passow, J. E., Sarkar, G., Ballman, K. V., Reid, J. M., Jenkins, R. B., Verhaak, R. G., Sulman, E. P., Kitange, G. J. & Sarkaria, J. N., May 1 2016, In : Journal of the National Cancer Institute. 108, 5, djv369.

Research output: Contribution to journalArticle

temozolomide
Methyltransferases
Glioblastoma
Biomarkers
Heterografts
7 Citations (Scopus)

Neuroprotection mediated by inhibition of calpain during acute viral encephalitis

Howe, C. L., Lafrance-Corey, R. G., Mirchia, K., Sauer, B. M., McGovern, R. M., Reid, J. M. & Buenz, E. J., Jun 27 2016, In : Scientific Reports. 6, 28699.

Research output: Contribution to journalArticle

Viral Encephalitis
Calpain
Ritonavir
Neurons
Picornaviridae Infections
46 Citations (Scopus)

Phase I study of the aurora A kinase inhibitor alisertib in combination with irinotecan and temozolomide for patients with relapsed or refractory neuroblastoma: A nant (new approaches to neuroblastoma therapy) trial

DuBois, S. G., Marachelian, A., Fox, E., Kudgus, R. A., Reid, J. M., Groshen, S., Malvar, J., Bagatell, R., Wagner, L., Maris, J. M., Hawkins, R., Courtier, J., Lai, H., Goodarzian, F., Shimada, H., Czarnecki, S., Tsao-Wei, D., Matthay, K. K. & Mosse, Y. P., Apr 20 2016, In : Journal of Clinical Oncology. 34, 12, p. 1368-1375 8 p.

Research output: Contribution to journalArticle

irinotecan
temozolomide
Aurora Kinase A
Neuroblastoma
Maximum Tolerated Dose
5 Citations (Scopus)

Serum triamcinolone levels following interlaminar epidural injection

Hooten, W. M., Nicholson, W. T., Gazelka, H. M., Reid, J. M., Moeschler, S. M. & Lamer, T. J., 2016, In : Regional Anesthesia and Pain Medicine. 41, 1, p. 75-79 5 p.

Research output: Contribution to journalArticle

Epidural Injections
Triamcinolone
Steroids
Serum
Pharmacokinetics
2015
40 Citations (Scopus)

A phase 1 dosing study of ruxolitinib in children with relapsed or refractory solid tumors, leukemias, or myeloproliferative neoplasms: A Children's Oncology Group phase 1 consortium study (ADVL1011)

Loh, M. L., Tasian, S. K., Rabin, K. R., Brown, P., Magoon, D., Reid, J. M., Chen, X., Ahern, C. H., Weigel, B. J. & Blaney, S. M., Oct 1 2015, In : Pediatric Blood and Cancer. 62, 10, p. 1717-1724 8 p.

Research output: Contribution to journalArticle

Leukemia
Neoplasms
Pharmacokinetics
Hematologic Neoplasms
S 6
12 Citations (Scopus)

A phase I study of cixutumumab (IMC-A12) in combination with temsirolimus (CCI-779) in children with recurrent solid tumors: A Children's Oncology Group phase I consortium report

Fouladi, M., Perentesis, J. P., Wagner, L. M., Vinks, A. A., Reid, J. M., Ahern, C., Thomas, G., Mercer, C. A., Krueger, D. A., Houghton, P. J., Doyle, L. A., Chen, H., Weigel, B. & Blaney, S. M., Apr 1 2015, In : Clinical Cancer Research. 21, 7, p. 1558-1565 8 p.

Research output: Contribution to journalArticle

Neoplasms
Pharmacokinetics
Area Under Curve
Blood Cells
temsirolimus
3 Citations (Scopus)

Characterization of batracylin-induced renal and bladder toxicity in rats

Davis, M., Bunin, D. I., Samuelsson, S. J., Altera, K. P., Kinders, R. J., Lawrence, S. M., Ji, J., Ames, M. M., Buhrow, S. A., Walden, C., Reid, J. M., Rausch, L. L. & Parman, T., Jun 4 2015, In : Toxicologic Pathology. 43, 4, p. 519-529 11 p.

Research output: Contribution to journalArticle

batracylin
Toxicity
Rats
Urinary Bladder
Kidney
7 Citations (Scopus)

Evaluation of CYP2D6 enzyme activity using a 13C-dextromethorphan breath test in women receiving adjuvant tamoxifen

Safgren, S. L., Suman, V. J., Kosel, M. L., Gilbert, J. A., Buhrow, S. A., Black, J. L., Northfelt, D. W., Modak, A. S., Rosen, D., Ingle, J. N., Ames, M. M., Reid, J. M. & Goetz, M. P., Mar 27 2015, In : Pharmacogenetics and Genomics. 25, 4, p. 157-163 7 p.

Research output: Contribution to journalArticle

Dextromethorphan
Cytochrome P-450 CYP2D6
Breath Tests
Tamoxifen
Enzymes
17 Citations (Scopus)

Lack of effect of metformin on mammary carcinogenesis in nondiabetic rat and mouse models

Thompson, M., Grubbs, C. J., Bode, A., Reid, J. M., McGovern, R., Bernard, P. S., Stijleman, I. J., Green, J. E., Bennett, C., Juliana, M. M., Moeinpour, F., Steele, V. E. & Lubet, R. A., Mar 1 2015, In : Cancer Prevention Research. 8, 3, p. 231-239 9 p.

Research output: Contribution to journalArticle

Metformin
Carcinogenesis
Breast
Breast Neoplasms
Methylnitrosourea
7 Citations (Scopus)

Quantification of the impact of enzyme-inducing antiepileptic drugs on irinotecan pharmacokinetics and SN-38 exposure

Berg, A. K., Buckner, J. C., Galanis, E., Jaeckle, K. A., Ames, M. M. & Reid, J. M., Nov 1 2015, In : Journal of Clinical Pharmacology. 55, 11, p. 1303-1312 10 p.

Research output: Contribution to journalArticle

irinotecan
Anticonvulsants
Pharmacokinetics
Enzymes
Glioma
43 Citations (Scopus)

Re-induction chemoimmunotherapy with epratuzumab in relapsed acute lymphoblastic leukemia (ALL): Phase II results from Children's Oncology Group (COG) study ADVL04P2

Raetz, E. A., Cairo, M. S., Borowitz, M. J., Lu, X., Devidas, M., Reid, J. M., Goldenberg, D. M., Wegener, W. A., Zeng, H., Whitlock, J. A., Adamson, P. C., Hunger, S. P. & Carroll, W. L., Jul 1 2015, In : Pediatric Blood and Cancer. 62, 7, p. 1171-1175 5 p.

Research output: Contribution to journalArticle

Precursor Cell Lymphoblastic Leukemia-Lymphoma
Induction Chemotherapy
Residual Neoplasm
Drug Therapy
Hematologic Neoplasms
2014
22 Citations (Scopus)

A Phase i study of intermittently dosed vorinostat in combination with bortezomib in patients with advanced solid tumors

Deming, D. A., Ninan, J., Bailey, H. H., Kolesar, J. M., Eickhoff, J., Reid, J. M., Ames, M. M., McGovern, R. M., Alberti, D., Marnocha, R., Espinoza-Delgado, I., Wright, J., Wilding, G. & Schelman, W. R., 2014, In : Investigational New Drugs. 32, 2, p. 323-329 7 p.

Research output: Contribution to journalArticle

Neoplasms
Fatigue
Appointments and Schedules
Sarcoma
Thrombocytopenia
28 Citations (Scopus)

A phase I trial of MK-2206 in children with refractory malignancies: A Children's Oncology Group study

Fouladi, M., Perentesis, J. P., Phillips, C. L., Leary, S., Reid, J. M., Mcgovern, R. M., Ingle, A. M., Ahern, C. H., Ames, M. M., Houghton, P., Doyle, L. A., Weigel, B. & Blaney, S. M., 2014, In : Pediatric Blood and Cancer. 61, 7, p. 1246-1251 6 p.

Research output: Contribution to journalArticle

Appointments and Schedules
Exanthema
Neoplasms
Pharmacokinetics
Ependymoma
10 Citations (Scopus)

Comparative uterotrophic effects of endoxifen and tamoxifen in ovariectomized sprague-dawley rats

Schweikart, K. M., Eldridge, S. R., Safgren, S. L., Parman, T., Reid, J. M., Ames, M. M., Goetz, M. P. & Davis, M. A., Dec 29 2014, In : Toxicologic Pathology. 42, 8, p. 1188-1196 9 p.

Research output: Contribution to journalArticle

Tamoxifen
Sprague Dawley Rats
Rats
Estradiol
Estrogen Antagonists
26 Citations (Scopus)

Discordant in vitro and in vivo chemopotentiating effects of the PARP inhibitor veliparib in temozolomide-sensitive versus -resistant glioblastoma multiforme xenografts

Gupta, S. K., Mladek, A. C., Carlson, B. L., Boakye-Agyeman, F., Bakken, K. K., Kizilbash, S., Schroeder, M. A., Reid, J. M. & Sarkaria, J. N., Jul 15 2014, In : Clinical Cancer Research. 20, 14, p. 3730-3741 12 p.

Research output: Contribution to journalArticle

temozolomide
Glioblastoma
Heterografts
DNA Damage
Poly(ADP-ribose) Polymerase Inhibitors
14 Citations (Scopus)

Mouse pharmacokinetics and metabolism of the curcumin analog, 4-piperidinone,3,5-bis[(2-fluorophenyl)methylene]-acetate(3E,5E) (EF-24; NSC 716993)

Reid, J. M., Buhrow, S. A., Gilbert, J. A., Jia, L., Shoji, M., Snyder, J. P. & Ames, M. M., 2014, In : Cancer Chemotherapy and Pharmacology. 73, 6, p. 1137-1146 10 p.

Research output: Contribution to journalArticle

formic acid
Curcumin
Pharmacokinetics
Protein Binding
Metabolism
10 Citations (Scopus)

Pharmacokinetics of endoxifen and tamoxifen in female mice: Implications for comparative in vivo activity studies

Reid, J. M., Goetz, M. P., Buhrow, S. A., Walden, C., Safgren, S. L., Kuffel, M. J., Reinicke, K. E., Suman, V. J., Haluska, P., Hou, X. & Ames, M. M., Oct 9 2014, In : Cancer Chemotherapy and Pharmacology. 74, 6, p. 1271-1278 8 p.

Research output: Contribution to journalArticle

Pharmacokinetics
Tamoxifen
Cytochrome P-450 CYP2D6
Metabolism
Area Under Curve
77 Citations (Scopus)

Phase 2 trial of cixutumumab in children, adolescents, and young adults with refractory solid tumors: A report from the Children's Oncology Group

Weigel, B., Malempati, S., Reid, J. M., Voss, S. D., Cho, S. Y., Chen, H. X., Krailo, M., Villaluna, D., Adamson, P. C. & Blaney, S. M., Mar 2014, In : Pediatric Blood and Cancer. 61, 3, p. 452-456 5 p.

Research output: Contribution to journalArticle

Young Adult
Neoplasms
Neuroblastoma
Insulin-Like Growth Factor Binding Protein 3
Rhabdomyosarcoma
22 Citations (Scopus)

Tuning pharmacokinetics and biodistribution of a targeted drug delivery system through incorporation of a passive targeting component

Kudgus, R. A., Walden, C. A., McGovern, R. M., Reid, J. M., Robertson, J. D. & Mukherjee, P., Jul 11 2014, In : Scientific Reports. 4, 5669.

Research output: Contribution to journalArticle

Drug Delivery Systems
Pharmacokinetics
Half-Life
Nanoconjugates
Intraperitoneal Injections
2013
31 Citations (Scopus)

A pediatric phase 1 trial of vorinostat and temozolomide in relapsed or refractory primary brain or spinal cord tumors: A children's oncology group phase 1 consortium study

Hummel, T. R., Wagner, L., Ahern, C., Fouladi, M., Reid, J. M., Mcgovern, R. M., Ames, M. M., Gilbertson, R. J., Horton, T., Ingle, A. M., Weigel, B. & Blaney, S. M., Sep 2013, In : Pediatric Blood and Cancer. 60, 9, p. 1452-1457 6 p.

Research output: Contribution to journalArticle

temozolomide
Spinal Cord Neoplasms
Pediatrics
Brain
Leukopenia
19 Citations (Scopus)

A phase i study of vorinostat in combination with bortezomib in patients with advanced malignancies

Schelman, W. R., Traynor, A. M., Holen, K. D., Kolesar, J. M., Attia, S., Hoang, T., Eickhoff, J., Jiang, Z., Alberti, D., Marnocha, R., Reid, J. M., Ames, M. M., McGovern, R. M., Espinoza-Delgado, I., Wright, J. J., Wilding, G. & Bailey, H. H., Dec 2013, In : Investigational New Drugs. 31, 6, p. 1539-1546 8 p.

Research output: Contribution to journalArticle

Maximum Tolerated Dose
Neoplasms
Fatigue
Bortezomib
vorinostat
29 Citations (Scopus)

A phase I trial of imetelstat in children with refractory or recurrent solid tumors: A children's oncology group phase I consortium study (ADVL1112)

Thompson, P. A., Drissi, R., Muscal, J. A., Panditharatna, E., Fouladi, M., Ingle, A. M., Ahern, C. H., Reid, J. M., Lin, T., Weigel, B. J. & Blaney, S. M., Dec 1 2013, In : Clinical Cancer Research. 19, 23, p. 6578-6584 7 p.

Research output: Contribution to journalArticle

Telomerase
Neoplasms
Pharmacokinetics
Lymphopenia
Ewing's Sarcoma
21 Citations (Scopus)

A phase I trial of vorinostat and alvocidib in patients with relapsed, refractory, or poor prognosis acute leukemia, or refractory anemia with excess blasts-2

Holkova, B., Supko, J. G., Ames, M. M., Reid, J. M., Shapiro, G. I., Perkins, E. B., Ramakrishnan, V., Tombes, M. B., Honeycutt, C., McGovern, R. M., Kmieciak, M., Shrader, E., Wellons, M. D., Sankala, H., Doyle, A., Wright, J., Roberts, J. D. & Grant, S., Apr 1 2013, In : Clinical Cancer Research. 19, 7, p. 1873-1883 11 p.

Research output: Contribution to journalArticle

alvocidib
Refractory Anemia with Excess of Blasts
Leukemia
Maximum Tolerated Dose
Pharmacokinetics